메뉴 건너뛰기




Volumn 25, Issue 4, 2014, Pages 318-327

Challenges in manufacturing adenoviral vectors for global vaccine product deployment

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VACCINE; ADENOVIRUS VECTOR; RECOMBINANT VACCINE;

EID: 84899089559     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2014.007     Document Type: Review
Times cited : (74)

References (56)
  • 3
    • 84871769381 scopus 로고    scopus 로고
    • First-in-human evaluation of the safety and immunogenicity of a recombinabf adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001)
    • Baden, L., et al. (2013). First-in-human evaluation of the safety and immunogenicity of a recombinabf adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001). J. Infect. Dis. 207, 240-247.
    • (2013) J. Infect. Dis. , vol.207 , pp. 240-247
    • Baden, L.1
  • 5
    • 0029838375 scopus 로고    scopus 로고
    • A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4
    • Brough, D., et al. (1996). A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4. J. Virol. 70, 6497-6501. (Pubitemid 26266881)
    • (1996) Journal of Virology , vol.70 , Issue.9 , pp. 6497-6501
    • Brough, D.E.1    Lizonova, A.2    Hsu, C.3    Kulesa, V.A.4    Kovesdi, I.5
  • 6
    • 27544495302 scopus 로고    scopus 로고
    • Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: Methods and implications
    • DOI 10.1038/sj.gt.3302611, PII 3302611
    • Burova, E., and Ioffe, E. (2005). Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications. Gene Ther. 12, S5-S17. (Pubitemid 41541749)
    • (2005) Gene Therapy , vol.12 , Issue.SUPPL. 1
    • Burova, E.1    Ioffe, E.2
  • 8
    • 72949097270 scopus 로고    scopus 로고
    • Purification of adenovirus vectors by combined anion exchange and gel filtration chromatography
    • Eglon, M., Duffy, A., O'Brien, T., and Strappe, P. (2009). Purification of adenovirus vectors by combined anion exchange and gel filtration chromatography. J. Gene Med. 11, 978-989.
    • (2009) J. Gene Med. , vol.11 , pp. 978-989
    • Eglon, M.1    Duffy, A.2    O'Brien, T.3    Strappe, P.4
  • 13
    • 84899067055 scopus 로고    scopus 로고
    • FDA Gene Therapy Letter Available at (Accessed February 28, 2014)
    • FDA Gene Therapy Letter. 2000). Gene Therapy Letter: Preclinical and Clinical Issues. Available at http://www.fda.gov/ohrms/dockets/ac/01/briefing/ 3739b1-05.pdf (Accessed February 28, 2014).
    • (2000) Gene Therapy Letter: Preclinical and Clinical Issues
  • 15
    • 0037081381 scopus 로고    scopus 로고
    • Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes
    • DOI 10.1016/S0264-410X(01)00450-9, PII S0264410X01004509
    • Gilbert, S., et al. (2002). Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes. Vaccine 20, 1039-1045. (Pubitemid 34135938)
    • (2002) Vaccine , vol.20 , Issue.7-8 , pp. 1039-1045
    • Gilbert, S.C.1    Schneider, J.2    Hannan, C.M.3    Hu, J.T.4    Plebanski, M.5    Sinden, R.6    Hill, A.V.S.7
  • 18
    • 21344468852 scopus 로고    scopus 로고
    • Development of a novel adenovirus purification process utilizing selective precipitation of cellular DNA
    • DOI 10.1002/bit.20406
    • Goerke, A., et al. (2005b). Development of a novel adenovirus purification process utilizing selective precipitation of cellular DNA. Biotechnol. Bioeng., 91, 12-21. (Pubitemid 40910748)
    • (2005) Biotechnology and Bioengineering , vol.91 , Issue.1 , pp. 12-21
    • Goerke, A.R.1    To, B.C.S.2    Lee, A.L.3    Sagar, S.L.4    Konz, J.O.5
  • 19
    • 0017710978 scopus 로고
    • Characteristics of a human cell line transformed by DNA from human adenovirus type 5
    • Graham, F., Smiley, J., Russell, W., and Nairn, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-74.
    • (1977) J. Gen. Virol. , vol.36 , pp. 59-74
    • Graham, F.1    Smiley, J.2    Russell, W.3    Nairn, R.4
  • 24
    • 0028825639 scopus 로고
    • Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography
    • Huyghe, B., et al. (1995). Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography. Hum. Gene Ther. 6, 1403-1416.
    • (1995) Hum. Gene Ther. , vol.6 , pp. 1403-1416
    • Huyghe, B.1
  • 25
    • 18144363442 scopus 로고    scopus 로고
    • Advanced methods of adenovirus vector production for human gene therapy: Roller bottles, microcarriers, and hollow fibers
    • September/October
    • Isayeva, T., Kotova, O., Kranshykh, V., and Kotov, A. (2003). Advanced methods of adenovirus vector production for human gene therapy: roller bottles, microcarriers, and hollow fibers. Bioprocess. J. September/October, 75-81.
    • (2003) Bioprocess. J. , pp. 75-81
    • Isayeva, T.1    Kotova, O.2    Kranshykh, V.3    Kotov, A.4
  • 26
    • 68549097881 scopus 로고    scopus 로고
    • Spread of epidemic keratoconjunctivitis due to a novel serotype of human adenovirus in Japan
    • Ishiko, H., and Aoki, K. (2009). Spread of epidemic keratoconjunctivitis due to a novel serotype of human adenovirus in Japan. J. Clin. Microbiol. 47, 2678-2679.
    • (2009) J. Clin. Microbiol. , vol.47 , pp. 2678-2679
    • Ishiko, H.1    Aoki, K.2
  • 27
    • 3042704538 scopus 로고    scopus 로고
    • Development and optimization of an adenovirus production process
    • DOI 10.1002/jgm.503
    • Kamen, A., and Henry, O. (2004). Development and optimization of an adenovirus production process. J. Gene Med. 6, S184-S192. (Pubitemid 40228027)
    • (2004) Journal of Gene Medicine , vol.6 , Issue.SUPPL. 1
    • Kamen, A.1    Henry, O.2
  • 29
    • 41949119694 scopus 로고    scopus 로고
    • WHO Study Group on cell substrates for production of biologicals, Geneva, Switzerland, 11-12 June 2007
    • Knezevic, I., et al. (2008). WHO Study Group on cell substrates for production of biologicals, Geneva, Switzerland, 11-12 June 2007. Biologicals 36, 203-211.
    • (2008) Biologicals , vol.36 , pp. 203-211
    • Knezevic, I.1
  • 30
    • 16344374932 scopus 로고    scopus 로고
    • Development of a purification process for adenovirus: Controlling virus aggregation to improve the clearance of host cell DNA
    • DOI 10.1021/bp049644r
    • Konz, J., Lee, A., Lewis, J., and Sagar, S. (2005). Development of a purification process for adenovirus: controlling virus aggregation to improve the clearance of host cell DNA. Biotechnol. Prog. 21, 466-472. (Pubitemid 40466419)
    • (2005) Biotechnology Progress , vol.21 , Issue.2 , pp. 466-472
    • Konz, J.O.1    Lee, A.L.2    Lewis, J.A.3    Sagar, S.L.4
  • 31
    • 33846013953 scopus 로고    scopus 로고
    • High-performance liquid chromatography method for rapid assessment of viral particle number in crude adenoviral lysates of mixed serotype
    • DOI 10.1038/sj.gt.3302851, PII 3302851
    • Kuhn, I., et al. (2007). High-performance liquid chromatography method for rapid assessment of viral particle number in crude adenoviral lysates of mixed serotype. Gene Ther. 14, 180-184. (Pubitemid 46043823)
    • (2007) Gene Therapy , vol.14 , Issue.2 , pp. 180-184
    • Kuhn, I.1    Larsen, B.2    Gross, C.3    Hermiston, T.4
  • 32
    • 57749179936 scopus 로고    scopus 로고
    • Improved purification of recombinant adenoviral vector by metal affinity membrane chromatography
    • Lee, D., Kim, B.M., and Seol, D. (2009). Improved purification of recombinant adenoviral vector by metal affinity membrane chromatography. Biochem. Biophys. Res. Commun. 378, 640-644.
    • (2009) Biochem. Biophys. Res. Commun. , vol.378 , pp. 640-644
    • Lee, D.1    Kim, B.M.2    Seol, D.3
  • 33
    • 0028658416 scopus 로고
    • Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells
    • Lochmuller, H., et al. (1994). Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells. Hum. Gene Ther. 5, 1485-1491.
    • (1994) Hum. Gene Ther. , vol.5 , pp. 1485-1491
    • Lochmuller, H.1
  • 34
    • 29744470594 scopus 로고    scopus 로고
    • Phylogenetic analysis of the main neutralization and hemagglutination determinants of all human adenovirus prototypes as a basis for molecular classification and taxonomy
    • DOI 10.1128/JVI.79.24.15265-15276.2005
    • Madisch, I., et al. (2005). Phylogenetic analysis of the main neutralization and hemagglutination determinants of all human adenovirus prototypes as a basis for molecular classification and taxonomy. J. Virol. 79, 15265-15276. (Pubitemid 43032309)
    • (2005) Journal of Virology , vol.79 , Issue.24 , pp. 15265-15276
    • Madisch, I.1    Harste, G.2    Pommer, H.3    Heim, A.4
  • 36
    • 83555170908 scopus 로고    scopus 로고
    • Performance characteristics of host-cell DNA quantification methods
    • Mehta, S., and Keer, J.T. (2007). Performance characteristics of host-cell DNA quantification methods. BioProcess International 5, 44-58.
    • (2007) Bio Process International , vol.5 , pp. 44-58
    • Mehta, S.1    Keer, J.T.2
  • 39
    • 77952953556 scopus 로고    scopus 로고
    • Massively parallel sequencing, a new method for detecting adventitious agents
    • Onions, D., and Kolman, J. (2010). Massively parallel sequencing, a new method for detecting adventitious agents. Biologicals 38, 377-380.
    • (2010) Biologicals , vol.38 , pp. 377-380
    • Onions, D.1    Kolman, J.2
  • 41
    • 84934439444 scopus 로고    scopus 로고
    • Canine adenovirus downstream processing protocol
    • M. Chillon and A. Bosch, eds. (Springer, New York)
    • Puig, M., Piedra, J., Miravet, S., and Segura, M. (2014). Canine adenovirus downstream processing protocol. In Adenovirus: Methods and Protocols. M. Chillon and A. Bosch, eds. (Springer, New York) pp. 197-210.
    • (2014) In Adenovirus: Methods and Protocols. , pp. 197-210
    • Puig, M.1    Piedra, J.2    Miravet, S.3    Segura, M.4
  • 42
  • 43
    • 84899081709 scopus 로고    scopus 로고
    • Available at Accessed February 25, 2014
    • Rolli, G. (2012). Progress toward a low COGs PER.C6 based IPV. Available at www.who.int/immunization-standards/vaccine-quality/rolli-crucell-progress- ipv-oct12.pdf (Accessed February 25, 2014)
    • (2012) Progress Toward A Low COGs PER.C6 Based IPV
    • Rolli, G.1
  • 44
    • 84899051507 scopus 로고    scopus 로고
    • Available at Accessed February 26, 2014
    • Sachs, J., Kremer, M., and Hamoudi, A. (1999). The case for a vaccine purchase fund. Available at www.earth.columbia.edu/sitefiles/file/ Sachs%20Writing/1999/CIDMimeo-1999-CaseforaVaccinePurchaseFund-June1999.pdf (Accessed February 26, 2014)
    • (1999) The Case for A Vaccine Purchase Fund
    • Sachs, J.1    Kremer, M.2    Hamoudi, A.3
  • 45
    • 80052308543 scopus 로고    scopus 로고
    • Overview of current scalable methods for purification of viral vectors
    • O. Merten and M. Al-Rubeai, eds. (Springer Science and Business Media, New York)
    • Segura, M., Kamen, A., and Garnier, A. (2011). Overview of current scalable methods for purification of viral vectors. In Viral Vectors for Gene Therapy: Methods and Protocols. O. Merten and M. Al-Rubeai, eds. (Springer Science and Business Media, New York) pp. 89-116.
    • (2011) In Viral Vectors for Gene Therapy: Methods and Protocols , pp. 89-116
    • Segura, M.1    Kamen, A.2    Garnier, A.3
  • 50
    • 80053528637 scopus 로고    scopus 로고
    • Computational analysis of two species C human adenoviruses provides evidence of a novel virus
    • Walsh, M.P., et al. (2011). Computational analysis of two species C human adenoviruses provides evidence of a novel virus. J. Clin. Microbiol. 49, 3482-3490.
    • (2011) J. Clin. Microbiol. , vol.49 , pp. 3482-3490
    • Walsh, M.P.1
  • 51
    • 22044436145 scopus 로고    scopus 로고
    • Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: Toward a universal method for the facile quantitation of virus and vector potency
    • DOI 10.1016/j.vaccine.2005.04.023, PII S0264410X05004627
    • Wang, F., et al. (2005). Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency. Vaccine 23, 4500-4508. (Pubitemid 40967978)
    • (2005) Vaccine , vol.23 , Issue.36 , pp. 4500-4508
    • Wang, F.1    Puddy, A.C.2    Mathis, B.C.3    Montalvo, A.G.4    Louis, A.A.5    McMackin, J.L.6    Xu, J.7    Zhang, Y.8    Tan, C.Y.9    Schofield, T.L.10    Wolf, J.J.11    Lewis, J.A.12
  • 52
    • 33746267429 scopus 로고    scopus 로고
    • A robust approach for the quantitation of viral concentration in an adenoviral vector-based human immunodeficiency virus vaccine by real-time quantitative polymerase chain reaction
    • DOI 10.1089/hum.2006.17.728
    • Wang, L., et al. (2006). A robust approach for the quantitation of viral concentration in an adenoviral vector-based human immunodeficiency virus vaccine by real-time quantitative polymerase chain reaction. Hum. Gene Ther. 17, 728-740. (Pubitemid 44100718)
    • (2006) Human Gene Therapy , vol.17 , Issue.7 , pp. 728-740
    • Wang, L.1    Wang, C.J.2    Tan, C.Y.3    Hsu, D.4    Hennessey Jr., J.P.5
  • 54
  • 55
    • 84899062636 scopus 로고    scopus 로고
    • Available at Accessed February 26, 2014
    • Wilson, P. (2010). Available at http://www.oxfam.org/en/policy/giving- developing-countries-best-shot-vaccine-access (Accessed February 26, 2014)
    • (2010)
    • Wilson, P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.